Yoshiyuki Onda
5PUBLICATIONS
11CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|May 17, 2024
The lymphocyte/monocyte ratio predicts the efficacy of isatuximab plus pomalidomide in multiple myeloma patients.Yutaka Shimazu, Junya Kanda, Yoshiyuki Onda
|Dec 19, 2022
Monocyte or white blood cell counts and β2 microglobulin predict the durable efficacy of daratumumab with lenalidomide.Yutaka Shimazu, Junya Kanda, Hitomi Kaneko
|Jul 18, 2022
Dipeptidyl-peptidase 4 inhibitor increased and maintained platelet count in a patient with primary myelofibrosis.Shizuka Kaneko, Yoshiyuki Onda, Soichiro Sakamoto
|Jul 05, 2022
Real-world effectiveness and safety analysis of carfilzomib-lenalidomide-dexamethasone and carfilzomib-dexamethasone in relapsed/refractory multiple myeloma: a multicenter retrospective analysis.Yoshiyuki Onda, Junya Kanda, Hitomi Kaneko
|Oct 19, 2020
Detection of adenovirus hepatitis and acute liver failure in allogeneic hematopoietic stem cell transplant patients.Yoshiyuki Onda, Junya Kanda, Soichiro Sakamoto
Pageof 1
Frequent Collaborators
4 joint publications
Junya Kanda
3 joint publications
Yutaka Shimazu
1 joint publications
Shizuka Kaneko
1 joint publications
Shin-Ichi Fuchida
1 joint publications
Yuji Shimura
1 joint publications
Satoru Kosugi
1 joint publications
Mitsuhiro Matsuda
1 joint publications
Yasuhiro Tanaka
1 joint publications
Tomoki Ito
1 joint publications
Chihiro Shimazaki
